- Companies
- PharmX Technologies
PharmX Technologies Valuation Multiples
PharmX Technologies is valued at $38M as of October 2026, a 7.1x revenue multiple. In the last fiscal year, PharmX Technologies revenue was $5M and PharmX Technologies EBITDA was ($142K).
PharmX Technologies Overview
About PharmX Technologies
PharmX Technologies Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business.
Founded
1950
HQ
Employees
109
Website
Financials (Last FY)
EV
$38M
Valuation Multiples
Start free trialPharmX Technologies Financials
PharmX Technologies reported last fiscal year revenue of $5M and negative EBITDA of ($142K).
In the same fiscal year, PharmX Technologies generated $4M in gross profit, ($142K) in EBITDA losses, and had net loss of ($1M).
Revenue (LTM)
PharmX Technologies P&L
In the most recent fiscal year, PharmX Technologies reported revenue of $5M and EBITDA of ($142K).
PharmX Technologies is unprofitable as of last fiscal year, with gross margin of 83%, EBITDA margin of (3%), and net margin of (24%).
Financial data powered by Morningstar, Inc.
PharmX Technologies Stock Performance
PharmX Technologies has current market cap of $38M, and enterprise value of $38M.
Market Cap Evolution
PharmX Technologies' stock price is $0.06.
PharmX Technologies share price decreased by 13.7% in the last 30 days, and by 40.8% in the last year.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $38M | $38M | 0.0% | -13.7% | -27.5% | -40.8% | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPharmX Technologies Valuation Multiples
PharmX Technologies trades at 7.1x EV/Revenue multiple, and (264.5x) EV/EBITDA.
EV / Revenue (LTM)
PharmX Technologies Financial Valuation Multiples
As of October 19, 2026, PharmX Technologies has market cap of $38M and EV of $38M.
PharmX Technologies has a P/E ratio of (29.7x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified PharmX Technologies Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


PharmX Technologies Margins & Growth Rates
In the most recent fiscal year, PharmX Technologies reported gross margin of 83%, EBITDA margin of (3%), and net margin of (24%).
PharmX Technologies Margins
PharmX Technologies Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
PharmX Technologies Operational KPIs
PharmX Technologies' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.1M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
PharmX Technologies Competitors
PharmX Technologies competitors include SMAIO, Insung Information, Singular Health, ContextVision, Mach7 Technologies, Nano X Imaging, Rocket Doctor AI, Susmed, Maps and Deepnoid.
Most PharmX Technologies public comparables operate across EHR & Practice Management, Healthcare Software, B2B SaaS, HealthTech and Vertical SaaS.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $10M | ($1M) | 3.5x | 3.4x | (33.7x) | (17.3x) | |||
| $256M | ($648K) | 0.1x | - | (53.3x) | - | |||
| $992K | ($5M) | 30.7x | 17.5x | (6.6x) | (10.2x) | |||
| $11M | $633K | 2.6x | 2.3x | 46.0x | 12.3x | |||
| $14M | ($1M) | 1.5x | 1.2x | (21.2x) | (11.4x) | |||
| $13M | ($67M) | 0.9x | 0.7x | (0.2x) | - | |||
| $1M | ($10M) | 28.8x | 16.4x | (3.6x) | (3.3x) | |||
| $3M | ($2M) | 5.3x | 4.0x | (7.2x) | - | |||
This data is available for Pro users. Sign up to see all PharmX Technologies competitors and their valuation data. Start Free Trial | ||||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout PharmX Technologies
| When was PharmX Technologies founded? | PharmX Technologies was founded in 1950. |
| Where is PharmX Technologies headquartered? | PharmX Technologies is headquartered in Australia. |
| How many employees does PharmX Technologies have? | As of today, PharmX Technologies has over 109 employees. |
| Is PharmX Technologies publicly listed? | Yes, PharmX Technologies is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of PharmX Technologies? | PharmX Technologies trades under PHX ticker. |
| When did PharmX Technologies go public? | PharmX Technologies went public in 1973. |
| Who are competitors of PharmX Technologies? | PharmX Technologies main competitors include SMAIO, Insung Information, Singular Health, ContextVision, Mach7 Technologies, Nano X Imaging, Rocket Doctor AI, Susmed, Maps, Deepnoid. |
| What is the current market cap of PharmX Technologies? | PharmX Technologies' current market cap is $38M. |
| What is the current revenue of PharmX Technologies? | PharmX Technologies' last fiscal year revenue is $5M. |
| What is the current EV/Revenue multiple of PharmX Technologies? | Current revenue multiple of PharmX Technologies is 7.1x. |
| Is PharmX Technologies profitable? | No, PharmX Technologies is not profitable. |
| How many companies PharmX Technologies has acquired to date? | PharmX Technologies hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies PharmX Technologies has invested to date? | PharmX Technologies hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to PharmX Technologies
Lists including PharmX Technologies
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




